Breast Cancer PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Breast Cancer PDF full book. Access full book title Breast Cancer by Michael James Brennan. Download full books in PDF and EPUB format.
Author: Michael James Brennan
Publisher:
ISBN:
Category : Breast
Languages : en
Pages : 0
Get Book Here
Book Description
Author: Michael James Brennan
Publisher:
ISBN:
Category : Breast
Languages : en
Pages : 0
Get Book Here
Book Description
Author: Ouissam Al Jarroudi
Publisher: Springer Nature
ISBN: 303133602X
Category : Medical
Languages : en
Pages : 371
Get Book Here
Book Description
This book focuses on innovative treatment options for breast cancer, including surgery, radiotherapy, systemic therapy and of course immunotherapy that is changing outcomes in some aggressive breast cancer histotypes. Subsequent chapters also address the ongoing emerging research in the screening, diagnostics, and management of all subtypes of breast cancers. All current landscapes and future perspectives in each molecular subtype: luminal, HER2-positive, and triple-negative breast cancers are discussed within the different chapters. Breast cancer is still the most common cancer and cause of cancer deaths among women worldwide. The improvement of breast cancer outcome appears to be strictly related to the validation of precise biomarkers that enable us to better select personalized approaches in breast cancer management. The closing chapters deal with the challenges of conducting research in the era of precision medicine for cancer. The book is edited and authored by leading experts in this field and will be of interest for clinicians and scientists alike.
Author: A.N. Papaioannou
Publisher: Springer Science & Business Media
ISBN: 3642658415
Category : Medical
Languages : en
Pages : 320
Get Book Here
Book Description
Breast cancer is probably the most frequent and fatal neoplasm in women of the western world, and it causes more fear, suffering and morbidity than any other disease in our times. It is also one of the most costly diseases not only in "lost earnings" but also in terms of physical and psychic energy spent and skills used for the many aspects of its care. Furthermore, the incidence of this tumor is slowly but steadily increasing while our means of treating it remain ineffec tive in distressingly many patients. Breast cancer thus represents an increasing threat to public health. The clinician responsible for the management of patients with this distressing disease has found himself, in recent years more than ever before, in a very awkward state of uncertainty. Many of his tradi tional views or practices have been questioned. The new concepts challenging his position are based on evidence at times so esoteric that, being often unable to comprehend it, he may subconsciously tend to distrust it. To his further dismay, clinicians and investigators of equal caliber and repute in this field disagree so widely and on so many important issues that he can no longer refer to an authoritative source for guidance; his horizons are therefore blurred and the stage is set for confusion. Much of what underlies the current controversy stems from our ignorance concerning the etiology of breast cancer and our inability to comprehend the many eccentricities of its clinical behavior.
Author: Ouissam Al Jarroudi
Publisher: Springer
ISBN: 9783031336010
Category : Medical
Languages : en
Pages : 0
Get Book Here
Book Description
This book focuses on innovative treatment options for breast cancer, including surgery, radiotherapy, systemic therapy and of course immunotherapy that is changing outcomes in some aggressive breast cancer histotypes. Subsequent chapters also address the ongoing emerging research in the screening, diagnostics, and management of all subtypes of breast cancers. All current landscapes and future perspectives in each molecular subtype: luminal, HER2-positive, and triple-negative breast cancers are discussed within the different chapters. Breast cancer is still the most common cancer and cause of cancer deaths among women worldwide. The improvement of breast cancer outcome appears to be strictly related to the validation of precise biomarkers that enable us to better select personalized approaches in breast cancer management. The closing chapters deal with the challenges of conducting research in the era of precision medicine for cancer. The book is edited and authored by leading experts in this field and will be of interest for clinicians and scientists alike.
Author: Michael James Brennan
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 432
Get Book Here
Book Description
Author: José Baselga
Publisher:
ISBN:
Category :
Languages : en
Pages :
Get Book Here
Book Description
Author: Katherine H. R. Tkaczuk, MD
Publisher: Springer Publishing Company
ISBN: 1617052760
Category : Medical
Languages : en
Pages : 333
Get Book Here
Book Description
Handbook of Breast Cancer and related Breast Disease is a practical guide to the management of patients with breast malignancies and related non-neoplastic lesions. Written and edited by leading experts, this handbook focuses on the application of conventional and novel treatment strategies to the care of patients with nonmalignant breast disease and all stages of breast cancer. The handbook is organized chronologically, from screening, through diagnosis and management, to survivorship care and related medical issues. The bulk of these chapters provide evidence-based treatment strategies for all patient subsets, including how to manage patients with high risk breast lesions, invasive breast carcinoma at each stage, and with all known molecular subtypes of breast cancer. Surgical, radiation, and medical treatment options are all discussed for each stage of breast cancer including treatment approaches in pregnancy and for high risk lesions and Phyllodes. This handbook is a comprehensive yet concise resource for residents, fellows, and early-career practitioners. Community oncologists, breast surgeons, radiation oncologists, primary care practitioners, and OBGYNs will also find its concise review of new research and procedures to be very useful in this dynamic field of medicine. Key Features: Includes discussion of genomic testing in management of early stage breast cancer Covers adjuvant and neoadjuvant treatment approaches Includes short clinical trial reviews for quick update of study endpoints and results for reference in management of breast cancer Outlines strategies for survivorship issues Key points in each chapter highlight clinical pearls and summarize other important concepts
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 91
Get Book Here
Book Description
Author: Terry Smith
Publisher: Rosen Central
ISBN: 9781435837416
Category : Health & Fitness
Languages : en
Pages : 68
Get Book Here
Book Description
Examines the history of breast cancer, explains what it is, who gets it, available treatments, preventive measures, and research being done on the disease.
Author: Robert Bazell
Publisher: Random House
ISBN: 0307764982
Category : Health & Fitness
Languages : en
Pages : 241
Get Book Here
Book Description
Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients' cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn't otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient's bedside. Bazell's deft portraits introduce us to the remarkable people instrumental in Herceptin's history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon's research; and Marti Nelson, who inspired the activists who lobbied for a "compassionate use" program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science.
